CRYO Cryo-Save

 

TIDMCRYO 
 
RNS Number : 1518F 
Cryo-Save Group NV 
07 January 2010 
 

7 January 2009 
 
 
Cryo-Save Group N.V. 
 
 
New storage record, over 7,300 samples stored in Q4 2009 - up 18% on Q4 2008 
 
 
Cryo-Save Group N.V. (AIM/Euronext: CRYO, "Cryo-Save" or "the Group"), Europe's 
leading stem cell bank, stored over 7,300 samples in Q4 2009, up 18% over Q4 
2008 (6,200 samples). This is the highest quarterly storage volume to date for 
the Group. 
 
 
The total number of samples stored for the whole of 2009 increased by 11% to 
27,900 (2008: 25,200). The Group now stores in total over 120,000 samples. 
 
 
In Q4 2009, 1,300 customers opted to take up the Group's  additional service to 
store stem cells from the umbilical cord itself, as well as from the cord blood, 
bringing the total number of cord samples to 3,800. 
 
 
The Group expects to publish its results for the year to 31 December 2009 during 
the week commencing 22 March 2010. 
 
 
Marc Waeterschoot, Chief Executive, commented: 
 
 
"Despite difficult economic circumstances, the Group's double digit year on year 
growth for 2009 is very positive, and has been driven by the significant growth 
we have seen in Spain, Italy, Serbia and India. 
 
 
"With our leading international position, the further roll out of the umbilical 
cord service, combined with our profitability and healthy cash position, we are 
confident of maintaining our momentum in 2010." 
 
 
 
 
+-------------------------------------+----------------------------------+ 
| For further details:                |                                  | 
+-------------------------------------+----------------------------------+ 
|                                     |                                  | 
+-------------------------------------+----------------------------------+ 
| Cryo-Save Group                     |             + 31 (0) 575 548 998 | 
+-------------------------------------+----------------------------------+ 
| Marc Waeterschoot, Chief Executive  |                                  | 
| Arnoud van Tulder, Chief Financial  |                                  | 
| Officer                             |                                  | 
+-------------------------------------+----------------------------------+ 
|                                     |                                  | 
+-------------------------------------+----------------------------------+ 
| Daniel Stewart & Company plc        |            + 44 (0) 20 7776 6550 | 
+-------------------------------------+----------------------------------+ 
| Simon Leathers                      |                                  | 
+-------------------------------------+----------------------------------+ 
|                                     |                                  | 
+-------------------------------------+----------------------------------+ 
| College Hill                        |           + 44 (0) 20 7457 2020  | 
+-------------------------------------+----------------------------------+ 
| Adrian Duffield/Rozi Morris         |                                  | 
+-------------------------------------+----------------------------------+ 
 
 
About Cryo-Save 
 
 
With more than 120,000 samples saved, Cryo-Save is the leading stem cell bank in 
Europe and one of the fastest growing in the world. Driven by its international 
business strategy, Cryo-Save is now represented in 38 countries on three 
continents and has state-of-the-art processing facilities in Belgium, Germany, 
Dubai, India and France (under construction). 
Cryo-Save sets the highest quality standards in stem cell storage, as it aims to 
make an important contribution to conquer possible life-threatening diseases in 
the future. As a service to the public, Cryo-Save offers a Cost-free Family 
Donation Programme, free of charge, to families wishing to store their newborn's 
umbilical cord blood stem cells for a family member diagnosed with a 
life-threatening disease treatable by stem cells. The company is committed to 
further improve stem cell cryopreservation techniques, by participating in 
European Commission funded projects, in Universities and Hospitals. 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 TSTKKADPABKDBDK 
 

Cryo-Save (LSE:CRYO)
Gráfica de Acción Histórica
De Feb 2025 a Mar 2025

Cryo-Save (LSE:CRYO)
Gráfica de Acción Histórica
De Mar 2024 a Mar 2025